Burning Rock Biotech Ltd SEC filings BNR
Burning Rock Biotech Ltd has 169 filings in SEC EDGAR's recent list, going back to Nov 4, 2019. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2023 | — |
| CORRESP | Letter to the SEC | Aug 30, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 6, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2022 | — |
| CORRESP | Letter to the SEC | Aug 16, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2022 | — |
| CORRESP | Letter to the SEC | Jun 21, 2022 | — |
| UPLOAD | Letter from the SEC | May 16, 2022 | — |
| EFFECT | Filing | Dec 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| DRSLTR | Filing | Nov 13, 2020 | — |
| DRS | Filing | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| CERT | Filing | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| 8-A12B | Form 8-a | Jun 5, 2020 | — |
| CORRESP | Letter to the SEC | Jun 5, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| DRSLTR | Filing | Feb 18, 2020 | — |
| DRS/A | Filing | Feb 18, 2020 | — |
| DRSLTR | Filing | Jan 10, 2020 | — |
| DRS/A | Filing | Jan 10, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2019 | — |
| DRS/A | Filing | Dec 9, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2019 | — |
| DRSLTR | Filing | Nov 4, 2019 | — |
| DRS | Filing | Nov 4, 2019 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BNR (Nasdaq)
- Headquarters
- Guangzhou, Guangdong
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1792267
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.